Our integrative approach using network pharmacology and bioinformatics predicts that targeting the PIK3R1 gene and modulating the PI3K/Akt signaling pathway can ameliorate obesity. The gene discussed is PIK3CG; the disease is obesity due to melanocortin 4 receptor deficiency.